Pharma Journalist -

Clinical-stage pharmaceutical company, Imago BioSciences developing novel therapies for hematological and inflammatory diseases asserted FDA's acceptance of their Investigational New…
Read More...

Allergan plc asserted that the U.S Food and Drug Administration has approved Allergan's  supplemental New Drug Application to augment the use of AVYCAZ (ceftazidime and avibactam) to…
Read More...

With a view to permit cancer patients access to potentially life-saving treatments, Lazarex Cancer Foundation's push for FDA issuing new FDA guidelines was taken into account by the…
Read More...

Clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, Syndax Pharmaceuticals ventured into new Clinical collaboration with AstraZeneca to…
Read More...

Panacea Pharmaceuticals, a clinical stage bio-pharmaceutical company developing novel biologically--targeted cancer therapies and diagnostics declared the enrollment of patient in an…
Read More...

Yunnan Fuwai Hospital declares successful completion of clinical case of MitralStitch mitral valve repair system. The operation was jointly conducted by the team of Professor Pan…
Read More...

It is noteworthy that TVA Medical's everlinQ endoAVF System exhibited positive Clinical results using the everlinQ endoAVF System. An international meta-analysis of clinical experience…
Read More...

Ambry Genetics and Invicro partner to offer customized genomics and imaging services for the pharmaceutical and biotechnology industry, exhibiting profound emphasis on Oncology and…
Read More...

FDA permits a Phase II Clinical Trial in 60 stroke patients, NuvOx Pharma announced FDA approval to proceed to test its investigational drug product, dodecafluoropentane emulsion…
Read More...

In a strategic merger revelation, Seattle Genetics and Cascadian Therapeutics signed a definitive merger agreement under which Seattle Genetics has conceded to acquire Cascadian…
Read More...